Recent approaches in design of peptidomimetics for antimicrobial drug discovery research.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Mini-Reviews in Medical Chemistry

• Publication date

  2013-04-25

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.2174/1389557511313070010PMID 23621691
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Therapeutic antimicrobial peptides may compromise natural immunity

  2012cited by this paper
• A Comparison of Linear and Cyclic Peptoid Oligomers as Potent Antimicrobial Agents

  2012cited by this paper
• Lipo-γ-AApeptides as a new class of potent and broad-spectrum antimicrobial agents.

  2012cited by this paper
• Antimicrobial Peptides: Successes, Challenges and Unanswered Questions

  2011cited by this paper
• A synthetic antimicrobial peptidomimetic (LTX 109): stereochemical impact on membrane disruption.

  2011cited by this paper
• Antimicrobial peptides important in innate immunity

  2011cited by this paper
• Peptides and Proteins as a Continuing Exciting Source of Inspiration for Peptidomimetics

  2011cited by this paper
• Beyond natural antimicrobial peptides: multimeric peptides and other peptidomimetic approaches

  2011cited by this paper
• Antimicrobial Peptoids Are Effective against Pseudomonas aeruginosa Biofilms

  2011cited by this paper
• Synthetic mimics of antimicrobial peptides from triaryl scaffolds.

  2011cited by this paper
• Antibacterial Mechanism of Action of Arylamide Foldamers

  2011cited by this paper
• Efficacy of Antimicrobial Peptoids against Mycobacterium tuberculosis

  2011cited by this paper
• Identification of γ-AApeptides with potent and broad-spectrum antimicrobial activity.

  2011cited by this paper
• Non-hemolytic α-AApeptides as antimicrobial peptidomimetics.

  2011cited by this paper
• Host-defense peptides: from biology to therapeutic strategies

  2011cited by this paper
• Peptoid–Peptide Hybrid Backbone Architectures

  2010cited by this paper
• Design, synthesis and antimicrobial properties of non-hemolytic cationic alpha-cyclopeptoids.

  2010cited by this paper
• De novo design of antimicrobial polymers, foldamers, and small molecules: from discovery to practical applications.

  2010cited by this paper
• Short Alkylated Peptoid Mimics of Antimicrobial Lipopeptides

  2010cited by this paper
• De novo design and in vivo activity of conformationally restrained antimicrobial arylamide foldamers

  2009cited by this paper
• New strategies for the design of folded peptoids revealed by a survey of noncovalent interactions in model systems.

  2009cited by this paper
• Synthetic mimics of antimicrobial peptides--a versatile ring-opening metathesis polymerization based platform for the synthesis of selective antibacterial and cell-penetrating polymers.

  2009cited by this paper
• Peptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides

  2008cited by this paper
• Synthetic Mimic of Antimicrobial Peptide with Nonmembrane-Disrupting Antibacterial Properties

  2008cited by this paper
• Intranasal administration delivers peptoids to the rat central nervous system.

  2008cited by this paper
• A polymeric domain that promotes cellular internalization.

  2008cited by this paper
• Influence of lipid composition on membrane activity of antimicrobial phenylene ethynylene oligomers.

  2008cited by this paper
• Peptidomimetics, a synthetic tool of drug discovery.

  2008cited by this paper
• De novo designed synthetic mimics of antimicrobial peptides.

  2008cited by this paper
• Improving oral bioavailability of peptides by multiple N-methylation: somatostatin analogues.

  2008cited by this paper
• Synthetic mimics of antimicrobial peptides.

  2008cited by this paper
• Activity of an Antimicrobial Peptide Mimetic against Planktonic and Biofilm Cultures of Oral Pathogens

  2007cited by this paper
• Local and tunable n-->pi* interactions regulate amide isomerism in the peptoid backbone.

  2007cited by this paper
• Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing

  2007cited by this paper
• Synthetic antimicrobial oligomers induce a composition-dependent topological transition in membranes.

  2007cited by this paper
• Biomimetic facially amphiphilic antibacterial oligomers with conformationally stiff backbones.

  2006cited by this paper
• Amphiphilic poly(phenyleneethynylene)s can mimic antimicrobial peptide membrane disordering effect by membrane insertion.

  2006cited by this paper
• Experimental evolution of resistance to an antimicrobial peptide

  2006cited by this paper
• Membrane activity of biomimetic facially amphiphilic antibiotics.

  2006cited by this paper
• Controlling the shape and flexibility of arylamides: a combined ab initio, ab initio molecular dynamics, and classical molecular dynamics study.

  2006cited by this paper
• Ab initio calculations of intramolecular parameters for a class of arylamide polymers

  2006cited by this paper
• Antimicrobial activity of an abiotic host defense peptide mimic.

  2006cited by this paper
• Peptide Antimicrobial Agents

  2006cited by this paper
• Peptide-lipid interactions: insights and perspectives.

  2005cited by this paper
• Antimicrobial peptides: new candidates in the fight against bacterial infections.

  2005cited by this paper
• Peptoid-peptide hybrids as potent novel melanocortin receptor ligands.

  2005cited by this paper
• Simple, helical peptoid analogs of lung surfactant protein B.

  2005cited by this paper
• Simple oligomers as antimicrobial peptide mimics

  2005cited by this paper
• New peptidomimetic polymers for antifouling surfaces.

  2005cited by this paper
• Mammalian defensins in the antimicrobial immune response

  2005cited by this paper
• Controlling the conformation of arylamides: computational studies of intramolecular hydrogen bonds between amides and ethers or thioethers.

  2004cited by this paper
• Unexpected relationships between structure and function in alpha,beta-peptides: antimicrobial foldamers with heterogeneous backbones.

  2004cited by this paper
• Theta-defensins: cyclic antimicrobial peptides produced by binary ligation of truncated alpha-defensins.

  2004cited by this paper
• Nontoxic membrane-active antimicrobial arylamide oligomers.

  2004cited by this paper
• Trends in antimicrobial drug development: implications for the future.

  2004cited by this paper
• Tuning the hemolytic and antibacterial activities of amphiphilic polynorbornene derivatives.

  2004cited by this paper
• Antimicrobial peptides in animals and their role in host defences.

  2003cited by this paper
• Soft antibacterial agents.

  2003cited by this paper
• Mechanisms of Antimicrobial Peptide Action and Resistance

  2003cited by this paper
• Structure–activity relationships of de novo designed cyclic antimicrobial peptides based on gramicidin S

  2003cited by this paper
• Helical peptoid mimics of magainin-2 amide.

  2003cited by this paper
• Development of novel antibacterial peptides that kill resistant isolates.

  2002cited by this paper
• An anionic antimicrobial peptide from toad Bombina maxima.

  2002cited by this paper
• New poly(phenyleneethynylene)s with cationic, facially amphiphilic structures.

  2002cited by this paper
• Antimicrobial peptides of multicellular organisms

  2002cited by this paper
• De novo design of biomimetic antimicrobial polymers

  2002cited by this paper
• Structure-activity studies of 14-helical antimicrobial beta-peptides: probing the relationship between conformational stability and antimicrobial potency.

  2002cited by this paper
• A practical and highly active ruthenium-based catalyst that effects the cross metathesis of acrylonitrile.

  2002cited by this paper
• Dendritic polymers in biomedical applications: from potential to clinical use in diagnostics and therapy.

  2002cited by this paper
• From "carpet" mechanism to de-novo designed diastereomeric cell-selective antimicrobial peptides.

  2001cited by this paper
• Emerging mechanisms of fluoroquinolone resistance.

  2001cited by this paper
• Barrel-stave model or toroidal model? A case study on melittin pores.

  2001cited by this paper
• The development of L2X2Ru=CHR olefin metathesis catalysts: an organometallic success story.

  2001cited by this paper
• Peptoid oligomers with alpha-chiral, aromatic side chains: sequence requirements for the formation of stable peptoid helices.

  2001cited by this paper
• Antibacterial agents based on the cyclic D,L-alpha-peptide architecture.

  2001cited by this paper
• Antimicrobial Peptides: Properties and Applicability

  2001cited by this paper
• Crystallization of antimicrobial pores in membranes: magainin and protegrin.

  2000cited by this paper
• In-vitro activity and killing effect of polycationic peptides on methicillin-resistant Staphylococcus aureus and interactions with clinically used antibiotics.

  2000cited by this paper
• Defensins and Host Defense

  1999cited by this paper
• Bioinspired polymeric materials: in-between proteins and plastics.

  1999cited by this paper
• Designing polymers that mimic biomolecules.

  1999cited by this paper
• The lantibiotic nisin, a special case or not?

  1999cited by this paper
• Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes.

  1999cited by this paper
• Correlation between anti-bacterial activity and pore sizes of two classes of voltage-dependent channel-forming peptides.

  1999cited by this paper
• Cationic peptides: a new source of antibiotics.

  1998cited by this paper
• Mode of action of linear amphipathic alpha-helical antimicrobial peptides.

  1998cited by this paper
• Magainins as paradigm for the mode of action of pore forming polypeptides.

  1998cited by this paper
• Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions.

  1998cited by this paper
• A Small Molecule CXCR4 Inhibitor that Blocks T Cell Line–tropic HIV-1 Infection

  1997cited by this paper
• An antimicrobial peptide, magainin 2, induced rapid flip-flop of phospholipids coupled with pore formation and peptide translocation.

  1996cited by this paper
• Peptide antibiotics and their role in innate immunity.

  1995cited by this paper
• Antimicrobial activities of amphiphilic peptides covalently bonded to a water-insoluble resin

  1995cited by this paper
• Structure–activity studies on magainins and other host defense peptides

  1995cited by this paper
• Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds.

  1994cited by this paper
• Peptoids: a modular approach to drug discovery.

  1992cited by this paper
• All‐D‐magainin: chirality, antimicrobial activity and proteolytic resistance

  1990cited by this paper
• Channel-forming properties of cecropins and related model compounds incorporated into planar lipid membranes.

  1988cited by this paper
• Sequence and specificity of two antibacterial proteins involved in insect immunity

  1981cited by this paper

• Selectivity Modulation of Small Cationic Membrane-Active Cyclic Peptides with Broad-Spectrum Activity against Bacteria and Fungi.

  2026cites this paper
• Antimicrobial peptides for tackling cystic fibrosis related bacterial infections: A review.

  2022cites this paper
• Antimicrobial peptides as a potent therapeutic regimen to quench biofilm-mediated antimicrobial resistance

  2021cites this paper
• Chain-End Modifications and Sequence Arrangements of Antimicrobial Peptoids for Mediating Activity and Nano-Assembly

  2020cites this paper
• Resin Swelling in Mixed Solvents Analysed using Hansen Solubility Parameter Space.

  2019cites this paper
• Advances in biomolecule inspired polymeric material decorated interfaces for biological applications.

  2019cites this paper
• In silico-mediated virtual screening and molecular docking platforms for discovery of non β-lactam inhibitors of y-49 β-lactamase from Mycobacterium tuberculosis

  2018cites this paper
• Membrane Active Antimicrobial Peptides: Translating Mechanistic Insights to Design

  2018cites this paper
• Pharmapolymers in the 21st century: Synthetic polymers in drug delivery applications

  2018cites this paper
• One step access to oxindole-based β-lactams through Ugi four-center three-component reaction

  2018cites this paper
• The greening of peptide synthesis

  2017cites this paper
• Membrane Active Antimicrobial Peptides: Translating Mechanistic Insights to Design

  2017cites this paper
• New approaches to combat Porphyromonas gingivalis biofilms

  2017cites this paper
• Properties and design of antimicrobial peptides as potential tools against pathogens and malignant cells Propiedades y diseño de péptidos antimicrobianos como herramientas potenciales contra patógenos y células malignas

  2016cites this paper
• Calcium Phosphate as a Key Material for Socially Responsible Tissue Engineering

  2016cites this paper
• Peptoid morphology studies and its performance in inhibiting islet amyloid polypeptide

  2016cites this paper
• Calcium Phosphate as a Key Material for Socially Responsible Tissue Engineering.

  2016cites this paper
• Peptaibolin analogues by incorporation of α,α-dialkylglycines: synthesis and study of their membrane permeating ability

  2016cites this paper
• Amino acid modified xanthone derivatives: novel, highly promising membrane-active antimicrobials for multidrug-resistant Gram-positive bacterial infections.

  2015cites this paper
• Macroporous chitosan hydrogels: Effects of sulfur on the loading and release behaviour of amino acid-based compounds.

  2015cites this paper
• Fighting the Global Problem of Antimicrobial Resistance

  2015cites this paper
• Examination of a Structural Model of Peptidomimicry by Cyclic Acyldepsipeptide Antibiotics in Their Interaction with the ClpP Peptidase

  2015cites this paper
• Arginine-containing peptides as potent inhibitors of VIM-2 metallo-β-lactamase.

  2015cites this paper
• Peptoids for biomaterials science.

  2014cites this paper
• Derivatives of the Mouse Cathelicidin-Related Antimicrobial Peptide (CRAMP) Inhibit Fungal and Bacterial Biofilm Formation

  2014cites this paper
• Therapeutic strategies to combat antibiotic resistance.

  2014cites this paper
• Can the Rise of Foldamers Herald the Fall of Antibiotic

  2014cites this paper
• Development of novel membrane active lipidated peptidomimetics active against drug resistant clinical isolates.

  2014cites this paper
• Tolerance of yeast biofilm cells towards systemic antifungals

  2014cites this paper
• The OPEP protein model: from single molecules, amyloid formation, crowding and hydrodynamics to DNA/RNA systems.

  2014cites this paper
• Chemically Modified Peptide Scaffolds Target the CFTR-Associated Ligand PDZ Domain

  2014cites this paper
• Use of the antimicrobial peptide Epinecidin-1 to protect against MRSA infection in mice with skin injuries.

  2013cites this paper